Suchergebnisse - "Mehanna, Hisham"

PubPharm (252)

1

Advances and residual knowledge gaps in the neck management of head and neck squamous cell carcinoma patients with advanced nodal disease undergoing definitive (chemo)radiotherapy for their primary

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2024

von Carsuzaa, F. | Chabrillac, E. | Marcy, P. | +2

2

Advances in testing for human papillomavirus -mediated head and neck cancer

enthalten in: Current opinion in oncology | 2024

von Mehanna, H. | Alemany, L. | von Buchwald, C.

3

Essential data variables for a minimum dataset for head and neck cancer trials and clinical research : HNCIG consensus recommendations and database

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Baliga, S. | Abou-Foul, A. | Parente, P. | +33

4

Xevinapant plus radiotherapy in resected, high-risk, cisplatin-ineligible LA SCCHN : the phase III XRay Vision study design

enthalten in: Future oncology (London, England) | 2024

von Ferris, R. | Mehanna, H. | Schoenfeld, J. | +7

5

Spatiotemporal evolution and inter-patient heterogeneity in primary and recurrent/metastatic head and neck squamous cell carcinoma

enthalten in: ResearchSquare.com | 2024

von Kong, A. | Bresadola, L. | Weber, D. | +9

6

Development of the 'ACT now & check-it-out' intervention to support patient-initiated follow up for Head and Neck cancer patients

enthalten in: Patient education and counseling | 2024

von Matheson, L. | Greaves, C. | Duda, J. | +14

7

Developing and Validating a Multivariable Prognostic-Predictive Classifier for Treatment Escalation of Oropharyngeal Squamous Cell Carcinoma : The PREDICTR-OPC Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Mehanna, H. | Rapozo, D. | von Zeidler, S. | +32

8

CompARE : study protocol for a phase III randomised controlled platform trial comparing alternative regimens for escalating treatment of intermediate and high-risk oropharyngeal cancer

enthalten in: Trials | 2024

von Mehanna, H. | Gaunt, P. | Kong, A. | +20

9

Implementing the time-to-event continual reassessment method in the presence of partial orders in a phase I head and neck cancer trial

enthalten in: BMC medical research methodology | 2024

von Patel, A. | Brock, K. | Slade, D. | +5

10

Implementing the time-to-event continual reassessment method in the presence of partial orders in a phase I head and neck cancer trial

enthalten in: BMC medical research methodology | 2024

von Patel, A. | Brock, K. | Slade, D. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[26]